Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 41, 2011 - Issue 3
804
Views
45
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

Pharmacokinetics and first-pass elimination of metoprolol in rats: contribution of intestinal first-pass extraction to low bioavailability of metoprolol

, , , , &
Pages 243-251 | Received 08 Sep 2010, Accepted 03 Nov 2010, Published online: 03 Dec 2010

References

  • Boralli VB, Coelho EB, Lanchote VL. (2009). Influence of quinidine, cimetidine, and ketoconazole on the enantioselective pharmacokinetics and metabolism of metoprolol in rats. Chirality 21:886–893.
  • Borg KO, FelleniusE, Johansson R, Wallborg M. (1975). Pharmacokinetic studies of metoprolol-(3-h) in the rat and the dog. Acta Pharmacol Toxicol (Copenh) 36(Suppl. 5):104–115.
  • Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254.
  • Cao X, Gibbs ST, Fang L, Miller HA, Landowski CP, Shin HC, Lennernas H, Zhong Y, Amidon GL, Yu LX, Sun D. (2006). Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model. Pharm Res 23:1675–1686.
  • Cerqueira PM, Coelho EB, Geleilete TJ, Goldman GH, Lanchote VL. (2005). Influence of chronic renal failure on stereoselective metoprolol metabolism in hypertensive patients. J Clin Pharmacol 45:1422–1433.
  • Choi YH, Kim SG, Lee MG. (2006). Dose-independent pharmacokinetics of metformin in rats: Hepatic and gastrointestinal first-pass effects. J Pharm Sci 95:2543–2552.
  • Davies B, Morris T. (1993). Physiological parameters in laboratory animals and humans. Pharm Res 10:1093–1095.
  • Di Verniero CA, Silberman EA, Mayer MA, Opezzo JA, Taira CA, Höcht C. (2008). In vitro and in vivo pharmacodynamic properties of metoprolol in fructose-fed hypertensive rats. J Cardiovasc Pharmacol 51:532–541.
  • Du Souich P, Maurice H, Héroux L. (1995). Contribution of the small intestine to the first-pass uptake and systemic clearance of propranolol in rabbits. Drug Metab Dispos 23:279–284.
  • Duggleby RG. (1995). Analysis of enzyme progress curves by nonlinear regression. Meth Enzymol 249:61–90.
  • Gertz M, Harrison A, Houston JB, Galetin A. (2010). Prediction of human intestinal first-pass metabolism of 25 CYP3A substrates from in vitro clearance and permeability data. Drug Metab Dispos 38:1147–1158.
  • Ha HR, Follath F. (2004). Metabolism of antiarrhythmics. Curr Drug Metab 5:543–571.
  • Ito K, Iwatsubo T, Kanamitsu S, Nakajima Y, Sugiyama Y. (1998). Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport. Annu Rev Pharmacol Toxicol 38:461–499.
  • Lee JH, Lee MG. (2008). Telithromycin pharmacokinetics in rat model of diabetes mellitus induced by alloxan or streptozotocin. Pharm Res 25:1915–1924.
  • Lee MG, Chiou WL. (1983). Evaluation of potential causes for the incomplete bioavailability of furosemide: gastric first-pass metabolism. J Pharmacokinet Biopharm 11:623–640.
  • Lennernäs H. (1998). Human intestinal permeability. J Pharm Sci 87:403–410.
  • Madani S, Paine MF, Lewis L, Thummel KE, Shen DD. (1999). Comparison of CYP2D6 content and metoprolol oxidation between microsomes isolated from human livers and small intestines. Pharm Res 16:1199–1205.
  • Mizuma T. (2002). Kinetic impact of presystemic intestinal metabolism on drug absorption: experiment and data analysis for the prediction of in vivo absorption from in vitro data. Drug Metab Pharmacokinet 17:496–506.
  • Mizuma T, Tsuji A, Hayashi M. (2004). Does the well-stirred model assess the intestinal first-pass effect well? J Pharm Pharmacol 56:1597–1599.
  • Mostafavi SA, Foster RT. (2000). Pharmacokinetics of metoprolol enantiomers following single and multiple administration of racemate in rat. Int J Pharm 202:97–102.
  • Okabe H, Higashi T, Ohta T, Hashimoto Y. (2004). Intestinal absorption and hepatic extraction of propranolol and metoprolol in rats with bilateral ureteral ligation. Biol Pharm Bull 27:1422–1427.
  • Soucek P, Gut I. (1992). Cytochromes P-450 in rats: structures, functions, properties and relevant human forms. Xenobiotica 22:83–103.
  • Tanabe H, Taira S, Taguchi M, Hashimoto Y. (2007). Pharmacokinetics and hepatic extraction of metoprolol in rats with glycerol-induced acute renal failure. Biol Pharm Bull 30:552–555.
  • Wang BO, Semple HA. (1997). Inhibition of metoprolol metabolism by amino acids in perfused rat livers. Insights into the food effect? Drug Metab Dispos 25:287–295.
  • Yang J, Jamei M, Yeo KR, Tucker GT, Rostami-Hodjegan A. (2007). Prediction of intestinal first-pass drug metabolism. Curr Drug Metab 8:676–684.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.